Aiming for precision: CYP2C19 gene polymorphism and clopidogrel resistance in patients with peripheral artery disease

Thromb Res. 2024 Apr:236:240-241. doi: 10.1016/j.thromres.2024.03.010. Epub 2024 Mar 8.
No abstract available

MeSH terms

  • Clopidogrel* / pharmacology
  • Clopidogrel* / therapeutic use
  • Cytochrome P-450 CYP2C19 / genetics
  • Drug Resistance / genetics
  • Genotype
  • Humans
  • Peripheral Arterial Disease* / drug therapy
  • Peripheral Arterial Disease* / genetics
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Aggregation Inhibitors / therapeutic use
  • Polymorphism, Genetic

Substances

  • Clopidogrel
  • CYP2C19 protein, human
  • Cytochrome P-450 CYP2C19
  • Platelet Aggregation Inhibitors